Certified by Founder Lodge
Inspired Capital
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $20,000,000
368 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We back founders with transformative ideas, brilliant teams, and relentless determination. By leveraging our experience across consumer and enterprise technology, we strive to help businesses
| Company | Date | Round | Raised |
|---|---|---|---|
 Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
 Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
 Solace |
August, 23 ,2024 | Series A | $14,000,000 |
 QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
 Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
 Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
 Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
 QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
 Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
 Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
 Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf |
September, 07 ,2022 | Unknown | $20,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Habi |
May, 11 ,2022 | Series C | $200,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Finix |
August, 11 ,2022 | Series B | $30,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Nirvana |
September, 13 ,2024 | Series A | $24,200,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| QA Wolf - 80% Test Coverage in 4 Months |
July, 24 ,2024 | Series B | $36,000,000 |
| Duckbill |
September, 15 ,2023 | Series A | $33,000,000 |
| Teamshares |
August, 21 ,2023 | Series D | $245,000,000 |
| Canvas Medical |
July, 14 ,2022 | Series B | $24,000,000 |
| Axion Ray |
March, 13 ,2024 | Series A | $17,500,000 |
| Solace |
August, 23 ,2024 | Series A | $14,000,000 |
| Paragon |
August, 01 ,2022 | Series A | $13,000,000 |
Founderpath
Truework
Farther
TeamApt Inc.
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
Lula Commerce | $8,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)
